Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Susanna Nguy"'
Autor:
Kamilah Ali, Ehab M Abo-Ali, M D Kabir, Bethany Riggins, Susanna Nguy, Lisa Li, Ujala Srivastava, Su Mya Mya Thinn
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115744 (2014)
Plasma apolipoprotein (apo)D, a ubiquitously expressed protein that binds small hydrophobic ligands, is found mainly on HDL particles. According to studies of human genetics and lipid disorders, plasma apoD levels positively correlate with HDL-choles
Externí odkaz:
https://doaj.org/article/caa852b967f34daaaaf4b0ab23893b78
Publikováno v:
Breast Cancer Research and Treatment. 187:815-830
Anti-HER2 therapy delivered in the adjuvant setting for breast cancer is given in conjunction with cytotoxic chemotherapy. For HER2-positive (HER2+) patients who cannot tolerate chemotherapy, there is no randomized data regarding the role of anti-HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43f070d9a2be57b858cab4067b70f2b2
https://doi.org/10.1007/s10549-021-06115-9
https://doi.org/10.1007/s10549-021-06115-9
Publikováno v:
Cancer Research. 80:P1-18
Purpose: The development of trastuzumab has significantly improved prognosis and treatment of Her2 positive breast cancer. The efficacy of trastuzumab monotherapy is limited and thus standard of care is to combine trastuzumab with chemotherapy. Yet f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a830cffd475f574a7d269742732b08bf
https://doi.org/10.1158/1538-7445.sabcs19-p1-18-02
https://doi.org/10.1158/1538-7445.sabcs19-p1-18-02
Publikováno v:
Breast cancer research and treatment. 187(3)
Anti-HER2 therapy delivered in the adjuvant setting for breast cancer is given in conjunction with cytotoxic chemotherapy. For HER2-positive (HER2+) patients who cannot tolerate chemotherapy, there is no randomized data regarding the role of anti-HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a87eaeae3ba5fa87aa0aa9bd1ae5cf11
https://pubmed.ncbi.nlm.nih.gov/33590386
https://pubmed.ncbi.nlm.nih.gov/33590386
Autor:
Naamit K. Gerber, Susanna Nguy
Publikováno v:
Global Clinical Case Reports. :1-3
We present the case of a 55-year old postmenopausal female with bilateral early stage clinically node negative breast cancer who was treated with bilateral lumpectomy with axillary lymph node dissection revealing N1a nodal disease in her right breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d602ac91e674074a1627f63f57b84697
https://doi.org/10.31487/j.gccr.2019.01.04
https://doi.org/10.31487/j.gccr.2019.01.04
Autor:
George Miller, M. Liria, S. Taneja, B. Diskin, Jose R. Teruel, S. Osterman, K.L. Du, S. Adam, Susanna Nguy, Hesheng Wang, J.D. Domogauer, E. Li
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e543-e544
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09851065c09e6450a7da6fb06d8773b2
https://doi.org/10.1016/j.ijrobp.2020.07.1694
https://doi.org/10.1016/j.ijrobp.2020.07.1694
Autor:
Gillian G. Baptiste, Belen Sundberg, Mirhee Kim, Joshua Leinwand, Zennur Sekendiz, Juan A. Kochen Rossi, Ruben D. Salas, Emma Kurz, Gregor Werba, Sorin A. A. Shadaloey, George Miller, Ruonan Chen, Berk Aykut, Shanmugapriya Selvaraj, Kwan Ho Tang, Miguel Liria, Emma Kruger, Susanna Nguy, Carmine Fedele, Salma Adam, Eric Li, Jason Karlen, Gustavo Sanchez, Dongling Wu, Chandan Buttar, Kwok-Kin Wong, Brian Diskin, Ting Chen, Wei Wang, Mautin Hundeyin, Junjie Wang, Cynthia Loomis, Muhammad Israr Ul Haq, Mohammad Saad Farooq, Marcelo F. Cassini
Publikováno v:
Nature immunology. 21(4)
Programmed cell death protein 1 (PD-1) ligation delimits immunogenic responses in T cells. However, the consequences of programmed cell death 1 ligand 1 (PD-L1) ligation in T cells are uncertain. We found that T cell expression of PD-L1 in cancer was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f60064e33fc88215cd0e6cf4d6049d5
https://pubmed.ncbi.nlm.nih.gov/32198133
https://pubmed.ncbi.nlm.nih.gov/32198133
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Frontiers in Oncology
Frontiers in Oncology
Background: Human immunodeficiency virus (HIV) seropositivity may be associated with higher risk of local recurrence and poor survival in multiple malignancies. However, long-term disease control in HIV-positive patients with head and neck cancer (HN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a7ae67f27bd1dd2b30866bb03a964ea
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:S95-S96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::037818933849e440dd4870d316934650
https://doi.org/10.1016/j.ijrobp.2015.07.229
https://doi.org/10.1016/j.ijrobp.2015.07.229
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 33
Introduction- ApoD is a ubiquitously expressed protein that binds small hydrophobic ligands and is a minor component of lipoproteins. Polymorphisms of the human ApoD gene are associated with lipid abnormalities, specifically the reduction of HDL and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a41a644e4ce75f00ab822374726846f4
https://doi.org/10.1161/atvb.33.suppl_1.a104
https://doi.org/10.1161/atvb.33.suppl_1.a104